key: cord-0007505-tvpg9dwq
authors: Suzumura, Akio; Sawada, Makoto; Marunouchi, Tohru
title: Selective induction of interleukin-6 in mouse microglia by granulocyte-macrophage colony-stimulating factor
date: 1996-03-25
journal: Brain Res
DOI: 10.1016/0006-8993(95)01535-3
sha: 0a6b1d04aece4d54892d911e8367d0028ab78ee7
doc_id: 7505
cord_uid: tvpg9dwq

Astrocytes produce granulocyte/macrophage colony-stimulating factor (GM-CSF) and support the survival and proliferation of microglia. To study the functions of GM-CSF in the central nervous system (CNS), we examined the effects of GM-CSF on cytokine production by glial cells. GM-CSF induced interleukin-6 (IL-6) production by microglia, but not by astrocytes, in a dose-dependent manner as assessed by bioassay and the detection of IL-6 mRNA by reverse transcriptase-polymerase chain reaction (RT-PCR) analysis. GM-CSF did not induce tumor necrosis factor (TNF)a or IL-1 in microglia and astrocytes, whereas lipopolysaccharide induced all these cytokines. The induction of IL-6 by GM-CSF in microglia was completely inhibited by antibodies to GM-CSF. Neither IL-3 nor macrophage-CSF (M-CSF) induced IL-6 production in microglia. Given that IL-1 and TNFα, monokines derived from microglia, induce IL-6 production in astrocytes, but not in microglia, results indicate that astrocytes and microglia may mutually regulate IL-6 production by different cytokines.

Microglia, or brain macrophages, produce a variety of immunoregulatory cytokines, including interleukin-la (IL-la), IL-1/3, IL-5, IL-6, tumor necrosis factor-a (TNFa), and transforming growth factor-/3 (TGF/3) [5, 11, 31, 32, 34, 36] . Astrocytes, another type of glial cell, also produce various cytokines including IL-la, IL-1/3, IL-5, IL-6, IL-8, TNFo~, TGF/3, granulocyte-(G-CSF), macrophage-(M-CSF) and granulocyte/macrophage colony-stimulating factor (GM -CSF) [1, 7, 21, 22, 29, 32, 34, 36, 45, 46] . Some populations of astrocytes and microglia may also produce IL-3 [6, 9] , although we could not confirm in our mouse system [29] . Recently, we also showed that microglia and astrocytes produce IL-10 [25] . These various cytokines affect the functions of glial or neuronal cells and form a unique cytokine network in the central nervous system (CNS). Astrocytes regulate the functions of microglia via cytokines, among which, colony-stimulating factors (CSFs) such as IL-3, GM-CSF and M-CSF are potent regulators of microglial function.

Microglia express receptors for these CSFs [35] . M-CSF induces microglial proliferation and also activates lysosoreal enzymes in these cells, effects that are inhibited by antibodies to M-CSF receptors [33] . GM-CSF also induces proliferation of but does not activate lysosomal enzymes in microglia [42, 43] . IL-3 induces morphological changes in microglia and supports the survival of these cells in vitro [42, 43] . We recently showed that IL-3 induces class II major histocompatibility complex (MHC) antigen expression on microglia, whereas GM-CSF inhibits in a dose-dependent manner the expression of class II MHC antigens on microglia induced by interferon-y (IFN 7) [18] .

Recent evidence suggests that the regulation of cytokine production differs among different types of cells. Mitogenic and antigenic stimuli induce 1L-6 production in T cells [17] . Lipopolysaccharide (LPS), viral infection, and various cytokines also induce IL-6 production in a variety of cells, including monocyte-macrophages [13, 26] . M-CSF and GM-CSF induce IL-6 production in human monocytes [27] . However, the effects of these CSFs on cytokine production in the CNS are as yet unknown. We have now investigated the effects of astrocyte-derived CSFs on cytokine production by microglia. Recombinant murine GM-CSF, IL-3, IL-4, IL-10, and  TGF/31, as well as human M-CSF and IL-6 were obtained from Genzyme (Boston, MA). Monoclonal antibodies to mouse GM-CSF were provided by Dr. J. Schreurs (DNAX Research Institute of Molecular and Cellular Biology, Inc. Polo Alto, CA). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTI') was obtained from Sigma (St. Louis, MO), and Escherichia coli LPS was from Difco (Detroit, MI).

Primary mixed glial cell cultures were prepared as described previously [39] , from newborn C3H/HeN mice (Charles River Japan, Sizuoka, Japan). In brief, after the meninges were removed carefully, the brain was dissociated by passing it through a 320-/zm-pore nylon mesh. The cell suspension was washed with Hanks' balanced salt solution, triturated, and plated in 75-cm 2 culture flasks (Falcon 3024, Beckton-Dickinson, Lincoln Park, NJ) at a density equivalent to two brains per flask in 10 ml Eagle's minimum essential medium supplemented with 10% fetal calf serum, 5 /.~g/ml bovine insulin, and 0.2% glucose. Microglia were isolated on the 14th day by the 'shaking off' method previously described [40] ; the purity of the cultures was 97 to 100% as determined by immunostaining with Mac 1 antibodies (Hybriteck, San Diego, CA, used in 1:50 dilution). Astrocyte-enriched cultures were prepared from the primary mixed glial cell cultures by repetitive exposure to trypsin and replating [41] ; the purity of the cultures exceeded 95% as determined by indirect immuno-fluorescence staining with antibodies to glial fibrillary acidic protein [41] .

Microglia and astrocyte-enriched cultures were plated in 2.5 cm diameter culture dishes (Falcon 3001, Beckton Dickinson, Lincoln Park, NJ) at a density of 5 × 105/ml and incubated for 24 h in the absence or presence of graded concentrations of GM-CSF (0.1 to 100 U/ml), IL-3 (1 to 100 U/ml), M-CSF (1 to 100 U/ml), LPS (1 /.~g/ml) or IFNy (100 U/ml). In some experiments, various concentrations of antibodies to GM-CSF were added to microglia together with GM-CSF. The cell supernatant was then collected and stored at -70°C until monokine activities were assayed. The time course of cytokine induction by GM-CSF was investigated by collecting cell supernatants at 2, 4, 8, 12, and 24 h after stimulation with GM-CSF. After the remaining cells were washed three times with phosphate-buffered saline, total RNA was isolated from the cells by the method of Chomczynski and Sacchi [4] with some modifications. RNA(1 /xg) was subjected to first-strand cDNA synthesis at 37°C for 90 min with 50 U of recombinant moloney murine leukemia virus reverse transcriptase (Boehringer-Mannheim, Mannheim, Germany) and 0.2 /zg of DNA random hexamers. The reaction was terminated by boiling for 5 rain, and 2 /xl of the mixture were amplified by 30 of the polymerase chain reaction (PCR) cycles with 0.5 units of Taq polymerase (Promega, Madison, WI) and 0.5 /xg each of the sense and antisense primers. The thermal cycle profile was 1 min at 94°C, 1 min at 55°C, and 2 min at 72°C. A portion (5 /xl) of the PCR mixture was subjected to electrophoresis on a 2% agarose gel, which was then stained with ethidium bromide and photographed. The by Dr. K. Onozaki, Nagoya City University) [16] and MH-60 (from Dr. T. Hirano, Osaka University) [23] , respectively, and Mq-T colorimetric assay [34, 44] . TNF activity was determined by cytotoxicity to the L929 cell line as described [32] .

All experiments were performed at least in triplicate. Data are presented as means + S.D. and were analyzed by Student's t-test. A P value of < 0.05 was considered statistically significant.

GM-CSF, at doses of 0.1 to 100 U/ml, induced IL-6 production in microglia in a time-and dose-dependent manner, as assessed by bioassay with the IL-6 dependent cell line MH60 and MTT colorimetric assay ( Fig. 1) . At doses ofl to 100U/ml and time of >8h, the effect of GM-CSF on IL-6 production was statistically significant (P < 0.001) relative to unstimulated cultures at the corresponding times. The maximal effect of GM-CSF on IL-6 production was apparent after 12 h or 24 h of stimulation with each dose examined. The induction of IL-6 by GM-CSF was inhibited by antibodies to GM-CSF in a dose-dependent manner (Fig. 2) ; the inhibitory effects of the anti-GM-CSF antibodies was statistically significant (P < 0.001) at a dilution of 1:105, and the antibodies completely abolished the effect of GM-CSF (100 U/ml) at a dilution of 1:103. In contrast to its effect on microglia, GM-CSF did not induce IL-6 production in astrocytes. One to 100 U/ml GM-CSF did not induce IL-6 production by astrocytes (Fig. 3) . Among the CSFs, only GM-CSF, but not IL-3 or M-CSF, induced the IL-6 production in microglia ( Fig. 4) . The induction of monokine production by GM-CSF in microglia was specific for IL-6; GM-CSF had no effect on the production of IL-1 or TNFa, whereas LPS, used as a positive control, induced all three monokines (Fig. 4) . The induction of IL-6 production in microglia by GM-CSF was inhibited by IL-4 in a dose-dependent manner (Fig. 5) . GM-CSF induced the expression of IL-6 mRNA in microglia in a dose-dependent manner (Fig. 6) . The inhibition of GM-CSF-induced IL-6 production by IL-4 was also confirmed at the mRNA level (Fig. 6 ). IL-4 by itself did not induce IL-6 activity (Fig. 5) or IL-6 mRNA (Fig. 6 ).

IL-6 has important functions in a variety of biological processes [14] . In the CNS, IL-6 promotes the survival and differentiation of cholinergic neurons [12] and modulates the production of neurotrophin [7] . Both IL-6 mRNA and IL-6 receptor mRNA are present in the striatum of rat brain during postnatal development [8] , although we did not detect IL-6 mRNA in the developing mouse cerebral cortex [24] . High levels of IL-6 transcript are present in the adult rat hippocampus [8, 37] , suggesting that IL-6 may function as a neurotrophic factor in both the developing and adult brain in vivo. The concentration of IL-6 is increased in the cerebrospinal fluid of individuals infected with human immunodeficiency virus [20] , of patients with HTLV-1 associated myelopathy [28] and of patients with systemic lupus erythematosus [15] . IL-6 was detected in association with amyloid plaques in the cortex and hippocampus of individuals with Alzheimer's disease, whereas it was undetectable in control brains [2, 38] . IL-6 may thus be induced in certain pathological conditions and participate directly in the pathological process in either inflammatory or neurodegenerative diseases in the CNS.

IL-6 is produced by astrocytes and microglia in the CNS, and its receptors are expressed on these glial cells as well as neurons [1, 3, 34, 35] . In addition, neurons themselves may produce IL-6 [37, 47] . As in the immune system, IL-6 production is regulated differently in astrocytes and microglia. For example, IL-1 and TNFo~ induce the production of IL-6 in astrocytes but not in microglia [34] . Substance P also induces IL-6 production in astrocytes [10] . In human monocytes, IL-1, IFNT, M-CSF, and GM-CSF all induce IL-6 production [27] . However, with the exception of GM-CSF, these cytokines failed to induce IL-6 in microglia, the counterpart of monocytes/macrophages in the CNS. We show now, for the first time, that GM-CSF, which is produced by astrocytes in the CNS in response to appropriate stimuli [29] , induces IL-6 production in microglia. Because (i) microglia express GM-CSF receptor mRNA [35] , (ii) the effect of GM-CSF was completely inhibited by anti-GM-CSF antibodies, and (iii) other CSFs did not induce IL-6 production in microglia, the induction of IL-6 by GM-CSF appears to be a specific function of GM-CSF mediated by GM-CSF receptors on these cells. Although astrocytes also express GM-CSF receptor mRNA [35] , GM-CSF did not induce the production of IL-6 in astrocytes. The current data, together with our previous observation that IL-I and TNFa specifically induce IL-6 production in astrocytes, but not in microglia [34] , suggest that astrocytes and microglia may mutually regulate |L-6 production in the opposing cell type by different cytokines. The functions of the induced IL-6 in the CNS remain to be elucidated. However, it may exert neurotrophic effects, acting directly on neurons or indirectly via induction of neurotrophic factors as mentioned above. Alternatively, it may play a role on neuron-glia interaction by activating glial cells.

GM-CSF exerts a variety of functions in the CNS. It reportedly functions as a neurotrophic factor [19] , and induces the proliferation and the morphological transfor-mation to rod-shaped cells of microglia [42, 43] . Recently, we also showed that GM-CSF inhibits the IFNy-induced expression of class II MHC antigen on these cells [18] . We did not detect GM-CSF mRNA in the developing mouse cortex in vivo [24] , and unstimulated glial cells did not produce detectable amounts of GM-CSF [29] . Therefore, GM-CSF may neither function as a neurotrophic factor nor induce IL-6 production in the normal developing brain. However, both GM-CSF mRNA and protein are inducible in astrocytes by stimulation with LPS [22, 29, 45] . Axotomy of facial nerves results in a rapid increase in GM-CSF receptors in the facial motor nucleus, which suggests that GM-CSF may play a role in the pathophysiology in this area after axotomy [30] . Because microglia have very similar characteristics to monocytes/macrophages and are thought to play important roles in the development of various neurological disorders, the effects of GM-CSF on microglia may be crucial in the pathophysiology of these cells. These observations suggest that GM-CSF, when produced in the CNS, may function either as a proinflammatory cytokine by inducing the proliferation and activation of microglia and by inducing another proinflammatory cytokine, IL-6, in microglia, or as an inhibitory cytokine by suppressing immunoregulatory functions of microglia.

Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to lL-lbeta and tumor necrosis factor-alpha

lnterleukin-6 and a-2-macroglobulin indicate an acute phase state in Alzheimer's disease cortices

Induction and regulation of interleukin-6 gene expression in rat astrocytes

Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction

Differential expression of transforming growth factor-/31, /32, and /33 by glioblastoma cell, astrocytes, and microglia

In situ hybridization histochemistry localization of interleukin-3 mRNA in mouse brain

On the cellular source and function of interleukin-6 produced in the central nervous system in viral diseases

Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development

Rat microglial interleukin-3

Interleukin-6 secretion from human astrocytoma cell induced by substance P

Interleukin-1 of the central nervous system is produced by ameboid microglia

Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons form postnatal rat

Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts

Biological and clinical aspects of interleukin-6, lmmunol. Today

Elevated levels of inteleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement

Simple, sensitive and specific bioassay of interleukin-1

Regulation of BSF-2/IL-6 production by human mononuclear cells. Macrophage-dependent synthesis of BSF-2/1L-6 by T cells

lnterleukin -3 induce class II MHC antigen expression in microglia

Trophic effect of granulocyte-macrophage colony-stimulating factor on central cholinergic neurons in vitro

Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system

Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus

Production of hemopoietic colony-stimulating factors by astrocytes

Establishment of interleukin 6(IL-6)/B cell stimulatory factor 2(BSF-2)-dependent cell line and preparation of anti-IL-6/BSF-2 monoclonal antibodies

Expression of cytokines during glial differentiation

Production of interleukin-10 by mouse glial cells in culture

Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV

Regulation of the expression of IL-6 in human monocytes

Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-Iassociated myelopathy/tropical spastic paraparesis

Production of granuloeyte/macrophagc colony-stimulating factor by cultured astrocytes

Increase of macrophage colony-stimulating factor and granuloeyte-macrophagc colony-stimulating factor receptors in the regenerating rat facial nucleus

Monokinc production by microglial cell clones

Production of tumor necrosis factor-alpha by microglia and astrocytc in culture

Activation and proliferation of the isolated microglia by colonystimulating factor-I and possible involvement of protein kinase C

TNF alpha induces IL-6 production by astrocytes but not by microglia

Expression of cytokine receptors in cultured neuronal and glial cells

Production of interleukin-5 by mouse astrocytes and microglia in culture

Localization of intcrleukin-6 mRNA and interleukin-6 receptor mRNA in rat brain

Detection of interleukin-6 and a2-macroglobulin immunoreaetibity in cortex and hippocampus of Alzheimer's disease patients

The isolation and long-term culturc of oligodendrocytes from newborn mouse brain

MHC antigen expression on bulk isolated macrophage-microglia in vitro:induction of class !I MHC antigen expression by interferon

Induction of glial cell MHC antigen expression in neurotropic corona virus infection: characterization of the H-2 inducing soluble factor elaborated by infected brain cells

Effects of colony-stimulating factors on isolated microglia in vitro

Morphological transformation of microglia in vitro

Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro

Monokine modulation of human astroglial cell production of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor

Macrophage-and astrocyte-derived transforming growth factor b as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome

Expression of interleukin(IL)-l/3, IL-6 and their respective receptors in the normal rat brain and after injury

This work was supported in part by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Science and Culture (Grant C), the Japanese Ministry of Health and Welfare, the Human Science Foundation, and in part by the Science Research Promotion Fund from the Japanese Private School Promotion Foundation, Japan.